
Clinical cases of long-term use of rosuvastatin are presented with an estimation of its effect on the soft end (lipid profile) and hard end (number of heart attacks, strokes, heart failure, hospitalization for cardiovascular causes) points are given. The results of studies on rosuvastatin (ASTEROID, CORONA, METEOR, ORION, COSMOS) are presented. Clinical guidelines on the management of patients with stable ischemic heart disease are considered on the example of COURAGE trial.
safety, efficacy, эффективность, RM1-950, безопасность, атеросклероз, randomized clinical study, розувастатин, RC666-701, Diseases of the circulatory (Cardiovascular) system, рандомизированные клинические исследования, Therapeutics. Pharmacology, atherosclerosis, rosuvastatin
safety, efficacy, эффективность, RM1-950, безопасность, атеросклероз, randomized clinical study, розувастатин, RC666-701, Diseases of the circulatory (Cardiovascular) system, рандомизированные клинические исследования, Therapeutics. Pharmacology, atherosclerosis, rosuvastatin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
